SCMR 2023 Recognizing CMR As A Mainstream Clinical Tool
The Society for Cardiovascular Magnetic Resonance (SCMR) is holding its 26th annual session on January 25-28, in San Diego. Arterys will join...
Arterys is proud to announce further adoption, growth, and partnerships, including a lineup with Amazon HealthLake Imaging. These developments further realize Arterys' mission to reduce subjectivity and variability in clinical diagnosis by providing real-time, data-driven tools to physicians.
Arterys is working with AWS to launch Amazon HealthLake Imaging, a new HIPAA-eligible capability for storing, sharing, and analyzing medical images at petabyte scale, now available in preview. As an AWS Partner, Arterys is leveraging HealthLake Imaging to enhance performance and responsiveness across its applications, such as Lung AI, which helps physicians analyze and track lung nodules. Arterys will demonstrate the use of HealthLake Imaging in the AWS booth #6958 during RSNA.
HealthLake Imaging enables access to medical imaging data with sub-second image retrieval latencies at scale powered by cloud-native APIs and applications from AWS Partners. Providers eliminate the burden of infrastructure management and enable AI/ML to drive increased value from imaging data with support from other services. This allows providers to focus resources on meeting the growing demands of clinical workflows and delivering high-quality patient care.
Arterys CEO John Axerio-Cilies paints a picture of where Arterys is at right now:
“Arterys is at a pivotal point in time in which we are really uniquely positioned to scale our solutions. We’re excited to introduce new partnerships and product updates that support physicians in delivering personalized, data-driven patient care.”
Further developments are unfolding this month as well, including partnerships with DeepLook Medical and InferVision.
Arterys and DeepLook Medical join forces this month to improve oncology workflows through precision measurements. This is achieved through DeepLook’s FDA-cleared DL Precise™, an automated segmentation tool being added to the Arterys radiology platform. This partnership provides a one-click tool to automate the segmentation and measurement of suspicious objects in all imaging modalities.
Arterys and InferVision have partnered to offer an optimized AI-driven lung oncology workflow with FDA-cleared detection, segmentation, and follow-up. Using InferVision's automated selection of nodule types and automated Lung-rads scoring and RECIST increases reporting efficiency for physicians.
Arterys’ Breast AI solution has also seen a rapid expansion this month, with several new practices adopting the cloud-based option, including:
You can access details about these announcements from Artyers' latest press release here.
Discover more about Aterys! Connect with the Arterys team at Booth #4719 at the RSNA national conference in Chicago, November 27-November 30, 2022. See first-hand Arterys' capabilities and how the software helps physicians provide better patient care.
The Society for Cardiovascular Magnetic Resonance (SCMR) is holding its 26th annual session on January 25-28, in San Diego. Arterys will join...
The energy of RSNA 2022 held late last month has really come back from pre-pandemic levels. With a robust expo floor, 40,000+ excited attendees, more...
Arterys is proud to announce further adoption, growth, and partnerships, including a lineup with Amazon HealthLake Imaging. These developments...